Stem Cell Dysfunction in Diabetes: Causes, Consequences, and Therapeutics for Regenerative Medicine
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: closed (30 September 2020) | Viewed by 254
Special Issue Editor
Interests: cellular pharmacology; stem/progenitor cell and vascular biology; epigenetics; diabetes; cardiovascular disease; regenerative medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diabetes is associated with micro- and macrovascular complications that are the most prevalent causes of mortality and morbidity in diabetic patients. Over the years, numerous studies have demonstrated that diabetic complications are the result of molecular alteration, mainly induced by hyperglycemia, in a wide range of cell types, including stem cells. Stem cells and progenitor cells, through their ability to self-renew and commit to specialized effector cells, play an integral role in the maintenance of tissue homeostasis and repair. Their functional aberrations, which seem to persist even after return to normoglycemia (hyperglycemic memory), have direct implications on tissue function and in the pathogenesis of diabetic complication. The study of the molecular and epigenetic mechanisms involved in the alteration of stem cell biology has become attractive for understanding the pathophysiology of diabetic complications and for discovering novel therapies.
For this Special Issue of Applied Sciences, the following topics are welcomed: molecular and epigenetic mechanisms involved in diabetic stem cell dysfunction; consequences of diabetic stem cell alterations in regenerative medicine; and new therapeutic and molecular strategies in treating stem cells dysfunction. Further innovative proposals will be evaluated.
Dr. Maria Cristina Vinci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- stem and progenitor cell dysfunction
- epigenetics
- regenerative medicine
- hyperglycemic memory
